| 1 |
pulmonary arterial pressure
(371 times)
|
Pulmonary Medicine
(153 times)
|
PVR (68 times)
NO (33 times)
HPV (26 times)
|
1977 [Long term results after operation of patent ductus arteriosus or ventricular septal defect and pulmonary hypertension (author's transl)].
|
| 2 |
pulmonary arterial blood pressure
(5 times)
|
Physiology
(3 times)
|
MCT (2 times)
MO (2 times)
PH (2 times)
|
1993 Possible role of pulmonary blood volume in chronic hypoxic pulmonary hypertension.
|
| 3 |
4-piperidinyl-alanine
(3 times)
|
Biochemistry
(3 times)
|
Pya (3 times)
Aca (2 times)
Ama (2 times)
|
2001 S1 subsite specificity of a recombinant cysteine proteinase, CPB, of Leishmania mexicana compared with cruzain, human cathepsin L and papain using substrates containing non-natural basic amino acids.
|
| 4 |
pressure of pulmonary artery
(3 times)
|
Medicine
(2 times)
|
125IALI (2 times)
6-keto-PGF1 alpha (2 times)
ARDS (2 times)
|
1995 [Vasoactive intestinal polypeptide prevents injury of pulmonary vascular permeability due to xanthine with xanthine oxidase].
|
| 5 |
pulmonary pressure
(3 times)
|
General Surgery
(1 time)
|
Cdyn (1 time)
ETS (1 time)
Fa (1 time)
|
1987 Lung damage following lymph fistula preparation in sheep.
|
| 6 |
proteins, Partner of paired
(2 times)
|
Cell Biology
(1 time)
|
EMTs (1 time)
|
2011 The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1.
|
| 7 |
pulmonary arterial mean pressure
(2 times)
|
Pulmonary Medicine
(2 times)
|
ATP (1 time)
COPD (1 time)
CSA (1 time)
|
1990 Comparison of pulmonary and systemic effects of adenosine triphosphate in chronic obstructive pulmonary disease--ATP: a pulmonary controlled vasoregulator?
|
| 8 |
P. pacificus
(1 time)
|
Biology
(1 time)
|
---
|
2011 Pristionchus pacificus daf-16 is essential for dauer formation but dispensable for mouth form dimorphism.
|
| 9 |
PA pressure
(1 time)
|
Cardiology
(1 time)
|
PA (1 time)
PV (1 time)
|
1990 Alterations in elastin and collagen related to the mechanism of progressive pulmonary venous obstruction in a piglet model. A hemodynamic, ultrastructural, and biochemical study.
|
| 10 |
passive changes in pulmonary arterial pressure
(1 time)
|
Physiology
(1 time)
|
HPV (1 time)
Ppw (1 time)
|
1990 Effects of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs.
|
| 11 |
Peak airway pressure
(1 time)
|
Critical Care
(1 time)
|
CV (1 time)
HFPV (1 time)
Paw (1 time)
|
1984 Gas exchange during conventional and high-frequency pulse ventilation in the surfactant-deficient lung: influence of positive end-expiratory pressure.
|
| 12 |
permeability; pulmonary artery pressure
(1 time)
|
Biochemistry
(1 time)
|
AH (1 time)
NO (1 time)
Ppc (1 time)
|
2019 Ropivacaine inhibits pressure-induced lung endothelial hyperpermeability in models of acute hypertension.
|
| 13 |
perphenazine
(1 time)
|
Chemistry Techniques, Analytical
(1 time)
|
DLLME (1 time)
FASS (1 time)
Fpa (1 time)
|
2015 Sensitive detection of piperazinyl phenothiazine drugs by field-amplified sample stacking in capillary electrophoresis with dispersive liquid-liquid microextraction.
|
| 14 |
plethysmography; pulmonary artery pressure
(1 time)
|
Pulmonary Medicine
(1 time)
|
CRP (1 time)
IL (1 time)
TNF (1 time)
|
2006 Systemic inflammation in patients with COPD and pulmonary hypertension.
|
| 15 |
polycythemia, and lower pulmonary arterial pressures
(1 time)
|
Physiology
(1 time)
|
CO (1 time)
mPpa (1 time)
|
2014 Pulmonary circulation and gas exchange at exercise in Sherpas at high altitude.
|
| 16 |
positions and after phenylpropanolamine
(1 time)
|
Otolaryngology
(1 time)
|
---
|
1986 Effects of phenylpropanolamine on ostial and nasal patency in patients treated for chronic maxillary sinusitis.
|
| 17 |
preparations pulmonary artery pressure
(1 time)
|
Biochemistry
(1 time)
|
AP (1 time)
CP (1 time)
FFR (1 time)
|
1999 Effect of platelet activating factor (PAF) on pulmonary circulation in isolated rabbit lung.
|
| 18 |
pressure in the MPA
(1 time)
|
Physiology
(1 time)
|
CSA (1 time)
MPA (1 time)
MR (1 time)
|
2001 Noninvasive assessment of pulmonary arterial hypertension by MR phase-mapping method.
|
| 19 |
production and pulmonary arterial pressure
(1 time)
|
Physiology
(1 time)
|
eNO (1 time)
L-NMMA (1 time)
NO (1 time)
|
2001 Flow-mediated release of nitric oxide in isolated, perfused rabbit lungs.
|
| 20 |
propranolol, atropine, and ibuprofen on pulmonary artery pressure
(1 time)
|
Pulmonary Medicine
(1 time)
|
Cdyn (1 time)
|
1989 Mechanisms of late hemodynamic and airway dynamic responses to endotoxin in awake sheep.
|
| 21 |
protected L-phosphonophenylalanine
(1 time)
|
Biology
(1 time)
|
---
|
2009 Efficient synthesis of protected L-phosphonophenylalanine (Ppa) derivatives suitable for solid phase synthesis.
|
| 22 |
pulmonary artery hypertension
(1 time)
|
Physiology
(1 time)
|
---
|
1981 Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery.
|
| 23 |
pulmonary artery systolic pressure
(1 time)
|
Cardiology
(1 time)
|
VSD (1 time)
|
1986 Pulmonary arterial changes in patients with ventricular septal defects and severe pulmonary hypertension.
|
| 24 |
pulmonary inflow pressure
(1 time)
|
Pulmonary Medicine
(1 time)
|
GE (1 time)
Ppai (1 time)
|
1992 Effect of hydralazine on vascular mechanics in a canine lobar preparation of pulmonary embolism.
|
| 25 |
pulmonary vascular distensibility alpha was calculated from each
(1 time)
|
Pulmonary Medicine
(1 time)
|
---
|
2010 Exercise stress echocardiography for the study of the pulmonary circulation.
|
| 26 |
pulmonary vascular pressure
(1 time)
|
General Surgery
(1 time)
|
PGE1 (1 time)
|
1982 Prostaglandin infusion and endotoxin-induced lung injury.
|
A Search Service for Abbreviation / Long Form